1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medication Management in Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injection
1.2.4 Smear
1.3 Market by Application
1.3.1 Global Medication Management in Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medication Management in Oncology Market Perspective (2020-2031)
2.2 Medication Management in Oncology Growth Trends by Region
2.2.1 Global Medication Management in Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Medication Management in Oncology Historic Market Size by Region (2020-2025)
2.2.3 Medication Management in Oncology Forecasted Market Size by Region (2026-2031)
2.3 Medication Management in Oncology Market Dynamics
2.3.1 Medication Management in Oncology Industry Trends
2.3.2 Medication Management in Oncology Market Drivers
2.3.3 Medication Management in Oncology Market Challenges
2.3.4 Medication Management in Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medication Management in Oncology Players by Revenue
3.1.1 Global Top Medication Management in Oncology Players by Revenue (2020-2025)
3.1.2 Global Medication Management in Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Medication Management in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medication Management in Oncology Revenue
3.4 Global Medication Management in Oncology Market Concentration Ratio
3.4.1 Global Medication Management in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medication Management in Oncology Revenue in 2022
3.5 Medication Management in Oncology Key Players Head office and Area Served
3.6 Key Players Medication Management in Oncology Product Solution and Service
3.7 Date of Enter into Medication Management in Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medication Management in Oncology Breakdown Data by Type
4.1 Global Medication Management in Oncology Historic Market Size by Type (2020-2025)
4.2 Global Medication Management in Oncology Forecasted Market Size by Type (2026-2031)
5 Medication Management in Oncology Breakdown Data by Application
5.1 Global Medication Management in Oncology Historic Market Size by Application (2020-2025)
5.2 Global Medication Management in Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Medication Management in Oncology Market Size (2020-2031)
6.2 North America Medication Management in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Medication Management in Oncology Market Size by Country (2020-2025)
6.4 North America Medication Management in Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medication Management in Oncology Market Size (2020-2031)
7.2 Europe Medication Management in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Medication Management in Oncology Market Size by Country (2020-2025)
7.4 Europe Medication Management in Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medication Management in Oncology Market Size (2020-2031)
8.2 Asia-Pacific Medication Management in Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Medication Management in Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Medication Management in Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medication Management in Oncology Market Size (2020-2031)
9.2 Latin America Medication Management in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Medication Management in Oncology Market Size by Country (2020-2025)
9.4 Latin America Medication Management in Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medication Management in Oncology Market Size (2020-2031)
10.2 Middle East & Africa Medication Management in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Medication Management in Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Medication Management in Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 B. Braun Melsungen AG
11.1.1 B. Braun Melsungen AG Company Detail
11.1.2 B. Braun Melsungen AG Business Overview
11.1.3 B. Braun Melsungen AG Medication Management in Oncology Introduction
11.1.4 B. Braun Melsungen AG Revenue in Medication Management in Oncology Business (2020-2025)
11.1.5 B. Braun Melsungen AG Recent Development
11.2 Dana-Farber Cancer Institute
11.2.1 Dana-Farber Cancer Institute Company Detail
11.2.2 Dana-Farber Cancer Institute Business Overview
11.2.3 Dana-Farber Cancer Institute Medication Management in Oncology Introduction
11.2.4 Dana-Farber Cancer Institute Revenue in Medication Management in Oncology Business (2020-2025)
11.2.5 Dana-Farber Cancer Institute Recent Development
11.3 MedicoRx
11.3.1 MedicoRx Company Detail
11.3.2 MedicoRx Business Overview
11.3.3 MedicoRx Medication Management in Oncology Introduction
11.3.4 MedicoRx Revenue in Medication Management in Oncology Business (2020-2025)
11.3.5 MedicoRx Recent Development
11.4 McKesson Corporation
11.4.1 McKesson Corporation Company Detail
11.4.2 McKesson Corporation Business Overview
11.4.3 McKesson Corporation Medication Management in Oncology Introduction
11.4.4 McKesson Corporation Revenue in Medication Management in Oncology Business (2020-2025)
11.4.5 McKesson Corporation Recent Development
11.5 Kroger Specialty Pharmacy
11.5.1 Kroger Specialty Pharmacy Company Detail
11.5.2 Kroger Specialty Pharmacy Business Overview
11.5.3 Kroger Specialty Pharmacy Medication Management in Oncology Introduction
11.5.4 Kroger Specialty Pharmacy Revenue in Medication Management in Oncology Business (2020-2025)
11.5.5 Kroger Specialty Pharmacy Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Medication Management in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of Smear
Table 5. Global Medication Management in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Medication Management in Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Medication Management in Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Medication Management in Oncology Market Share by Region (2020-2025)
Table 9. Global Medication Management in Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Medication Management in Oncology Market Share by Region (2026-2031)
Table 11. Medication Management in Oncology Market Trends
Table 12. Medication Management in Oncology Market Drivers
Table 13. Medication Management in Oncology Market Challenges
Table 14. Medication Management in Oncology Market Restraints
Table 15. Global Medication Management in Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Medication Management in Oncology Market Share by Players (2020-2025)
Table 17. Global Top Medication Management in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication Management in Oncology as of 2022)
Table 18. Ranking of Global Top Medication Management in Oncology Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Medication Management in Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Medication Management in Oncology Product Solution and Service
Table 22. Date of Enter into Medication Management in Oncology Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Medication Management in Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Medication Management in Oncology Revenue Market Share by Type (2020-2025)
Table 26. Global Medication Management in Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Medication Management in Oncology Revenue Market Share by Type (2026-2031)
Table 28. Global Medication Management in Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Medication Management in Oncology Revenue Market Share by Application (2020-2025)
Table 30. Global Medication Management in Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Medication Management in Oncology Revenue Market Share by Application (2026-2031)
Table 32. North America Medication Management in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Medication Management in Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Medication Management in Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Medication Management in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Medication Management in Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Medication Management in Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Medication Management in Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Medication Management in Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Medication Management in Oncology Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Medication Management in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Medication Management in Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Medication Management in Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Medication Management in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Medication Management in Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Medication Management in Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 47. B. Braun Melsungen AG Company Detail
Table 48. B. Braun Melsungen AG Business Overview
Table 49. B. Braun Melsungen AG Medication Management in Oncology Product
Table 50. B. Braun Melsungen AG Revenue in Medication Management in Oncology Business (2020-2025) & (US$ Million)
Table 51. B. Braun Melsungen AG Recent Development
Table 52. Dana-Farber Cancer Institute Company Detail
Table 53. Dana-Farber Cancer Institute Business Overview
Table 54. Dana-Farber Cancer Institute Medication Management in Oncology Product
Table 55. Dana-Farber Cancer Institute Revenue in Medication Management in Oncology Business (2020-2025) & (US$ Million)
Table 56. Dana-Farber Cancer Institute Recent Development
Table 57. MedicoRx Company Detail
Table 58. MedicoRx Business Overview
Table 59. MedicoRx Medication Management in Oncology Product
Table 60. MedicoRx Revenue in Medication Management in Oncology Business (2020-2025) & (US$ Million)
Table 61. MedicoRx Recent Development
Table 62. McKesson Corporation Company Detail
Table 63. McKesson Corporation Business Overview
Table 64. McKesson Corporation Medication Management in Oncology Product
Table 65. McKesson Corporation Revenue in Medication Management in Oncology Business (2020-2025) & (US$ Million)
Table 66. McKesson Corporation Recent Development
Table 67. Kroger Specialty Pharmacy Company Detail
Table 68. Kroger Specialty Pharmacy Business Overview
Table 69. Kroger Specialty Pharmacy Medication Management in Oncology Product
Table 70. Kroger Specialty Pharmacy Revenue in Medication Management in Oncology Business (2020-2025) & (US$ Million)
Table 71. Kroger Specialty Pharmacy Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medication Management in Oncology Market Size Comparison by Type (2025-2031) & (US$ Million)
Figure 2. Global Medication Management in Oncology Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Smear Features
Figure 6. Global Medication Management in Oncology Market Size Comparison by Application (2025-2031) & (US$ Million)
Figure 7. Global Medication Management in Oncology Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Medication Management in Oncology Report Years Considered
Figure 12. Global Medication Management in Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Medication Management in Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Medication Management in Oncology Market Share by Region: 2022 VS 2029
Figure 15. Global Medication Management in Oncology Market Share by Players in 2024
Figure 16. Global Top Medication Management in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication Management in Oncology as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Medication Management in Oncology Revenue in 2024
Figure 18. North America Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Medication Management in Oncology Market Share by Country (2020-2031)
Figure 20. United States Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Medication Management in Oncology Market Share by Country (2020-2031)
Figure 24. Germany Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Medication Management in Oncology Market Share by Region (2020-2031)
Figure 32. China Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Medication Management in Oncology Market Share by Country (2020-2031)
Figure 40. Mexico Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Medication Management in Oncology Market Share by Country (2020-2031)
Figure 44. Turkey Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Medication Management in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. B. Braun Melsungen AG Revenue Growth Rate in Medication Management in Oncology Business (2020-2025)
Figure 47. Dana-Farber Cancer Institute Revenue Growth Rate in Medication Management in Oncology Business (2020-2025)
Figure 48. MedicoRx Revenue Growth Rate in Medication Management in Oncology Business (2020-2025)
Figure 49. McKesson Corporation Revenue Growth Rate in Medication Management in Oncology Business (2020-2025)
Figure 50. Kroger Specialty Pharmacy Revenue Growth Rate in Medication Management in Oncology Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

※参考情報 腫瘍学用投薬管理は、がん患者における薬剤の適切な使用と管理を目的とする医療の一分野であり、その重要性は年々高まっています。腫瘍学は非常に特殊な分野であり、がんの種類や患者の個々の状態に応じて多様な治療法が存在します。それに伴い、投薬管理も複雑化しており、適切な管理が必要とされています。ここでは腫瘍学用投薬管理の概念、特徴、種類、用途、関連技術について詳しく説明いたします。 腫瘍学用投薬管理の定義としては、がん患者に対する薬物療法の選択、投与、効果評価、副作用の管理、患者教育などを包括的に行うことを指します。これには医療チームによる協力が不可欠であり、医師、看護師、薬剤師、栄養士、心理士など、さまざまな専門家が連携して患者に最適な治療を提供します。 特徴としては、まず、がん治療において使用される薬剤は非常に多様であり、化学療法、ホルモン療法、免疫療法、分子標的薬、組織適応型治療などがあります。それぞれの薬剤は異なる作用機序や副作用を持ち、個々の患者の状態に応じたきめ細かい調整が必要です。また、腫瘍学用の投薬管理は、患者の年齢や体重、合併症、そして個々のがんの特徴なども考慮に入れるため、パーソナル化医療の一環と言えます。 次に、腫瘍学での薬剤の種類について説明します。まず、化学療法薬は主に癌細胞を破壊する目的で使用されますが、正常細胞にも影響を与えるため副作用が生じることがあります。ホルモン療法は特定のホルモンが関与するがん、例えば乳がんや前立腺がんに対して用いられます。免疫療法は患者自身の免疫系を利用してがん細胞を攻撃する方法であり、近年注目されている治療法の一つです。また、分子標的薬は特定の遺伝子変異や分子異常をターゲットにし、より効果的な治療を提供します。これに加えて、最近では遺伝子治療や抗体療法も発展を遂げており、より個別化された治療が実現されつつあります。 腫瘍学用投薬管理の用途は広範囲にわたります。がんの初期治療においては、主に腫瘍を縮小させることを目的とし、治癒を目指す治療が行われます。一方で、がんの進行に伴い、緩和ケアや症状管理が主な目的となることもあります。これにより、患者の生活の質を向上させることが求められます。また、治療に伴う副作用の管理や、感染症予防、栄養サポートなども含まれます。 さらに、腫瘍学用投薬管理における関連技術についても触れたいと思います。たとえば、電子カルテや医療情報システムは、患者の情報を一元的に管理することで、投薬の履歴やアレルギー情報、副作用のチェックなどを迅速に行うことができます。また、投薬管理システムや薬剤支援システムは、適切な投与量の算出や治療効果のモニタリングを行う際に活用されます。最近では、AI技術を活用した個別化医療の進展も期待されており、患者の遺伝情報を基にした治療法の選定が進められています。 腫瘍学用投薬管理を行う際には、患者とのコミュニケーションが不可欠です。患者は治療に対して不安や疑問を持つことが多く、信頼関係を築くことが重要です。医療者は、患者に対して投薬の目的、期待される効果、副作用、生活習慣の改善等について十分に説明することが求められます。患者が自らの治療に積極的に参加できるような環境を整えることも、投薬管理の成功には欠かせない要素です。 結論として、腫瘍学用投薬管理は、がん治療における薬剤の適切な使用とその効果、副作用の管理を行う重要なプロセスです。多様ながんの治療に向けた医療チームの協力や、最新の医療技術を駆使することで、個々の患者に最適な治療が提供されることが期待されます。今後もこの分野の発展が進むことで、より多くの患者の治癒や生活の質の向上に寄与することができると考えられます。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/